Reumalääke

Reumalääke is a Finnish term that translates to "rheumatism medication" or "anti-rheumatic drug" in English. It refers to a broad category of medications used to treat rheumatic diseases, which are conditions affecting the joints, muscles, and connective tissues. These diseases can cause pain, stiffness, swelling, and reduced mobility.

The specific type of reumalääke prescribed depends on the underlying rheumatic condition. Common classes of drugs include nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, which help reduce pain and inflammation. For more severe or progressive conditions such as rheumatoid arthritis, disease-modifying antirheumatic drugs (DMARDs) are often used. These medications work by suppressing the immune system's overactivity that damages joints. Biologic DMARDs are a newer generation of DMARDs that target specific parts of the immune system. Corticosteroids, potent anti-inflammatory agents, may also be used short-term or long-term to manage symptoms.

The choice and dosage of reumalääke are determined by a healthcare professional based on the patient's diagnosis, symptom severity, and overall health. Treatment aims to alleviate pain, reduce inflammation, slow disease progression, and improve the patient's quality of life. It's important for individuals to follow their doctor's instructions regarding the use of these medications and to report any side effects promptly.